WAS and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, monitoring the expression of WASP could be useful as a molecular marker of progression of CML and may help in future therapeutic decisions, such as early switch to more potent TKI or to use combining chemotherapies.